<DOC>
	<DOCNO>NCT01015287</DOCNO>
	<brief_summary>The purpose trial investigate potential benefits/risks regard pretreatment prasugrel non-ST-elevation myocardial infarction ( NSTEMI ) participant elevate troponin schedule coronary angiography/percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>A Comparison Prasugrel PCI Time Diagnosis Non-ST Elevation Myocardial Infarction</brief_title>
	<detailed_description>This trial consist two arm . One arm non pre-treatment arm . Participants arm receive placebo immediately NSTEMI diagnosis prior diagnostic coronary angiography . A 60 mg prasugrel load dose give immediately coronary angiography proceed PCI . Subsequently , participant receive daily maintenance dos prasugrel day 30 . Participants great equal 75 year age body weight less 60 kilogram ( kg ) receive 5 mg oral dose daily . All others receive 10 mg oral daily maintenance dose 30 day . The arm pre-treatment arm participant receive split load dose regimen 30 mg prasugrel administer immediately NSTEMI diagnosis prior diagnostic coronary angiography . The remainder load dose ( 30 mg ) administer participant proceed PCI . Subsequently , participant receive daily maintenance dos prasugrel day 30 . Participants great equal 75 year age body weight less 60 kg receive 5 mg oral dose daily . All others receive 10 mg oral daily maintenance dose 30 day .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>Have acute coronary syndrome consist nonSTsegment elevation elevate troponin Scheduled coronary angiography/PCI great equal 2 less 24 hour time plan randomization , 48 hour randomization Must eligible treatment prasugrel , aspirin ( ASA ) , glycoprotein IIb/IIIa receptor ( GPIIb/IIIa ) inhibitor per respective label May maintenance dose clopidogrel 75 mg must able switch prasugrel Must enrol cardiac catheterization laboratory hospital hospital/ambulance service affiliate cardiac catheterization laboratory hospital Present STsegment elevation myocardial infarction ( STEMI ) time entry randomization Have cardiogenic shock Have refractory ventricular arrhythmia Have New York Heart Association ( NYHA ) Class IV congestive heart failure ( CHF ) Have cardiac arrest within 1 week entry randomization study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Acute Coronary Syndromes</keyword>
	<keyword>Heart Disease</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
	<keyword>P2Y12</keyword>
	<keyword>NSTEMI</keyword>
</DOC>